Zhu Xiao-Rong, Zhang Yong-Peng, Bai Lu, Zhang Xue-Lian, Zhou Jian-Bo, Yang Jin-Kui
Department of Endocrinology Department of Ophthalmology, Beijing Tongren Hospital, Capital Medical University Department of Geratology, Beijing Haidian Hospital Beijing Key Laboratory of Diabetes Research and Care, Beijing China.
Medicine (Baltimore). 2017 Jan;96(3):e5894. doi: 10.1097/MD.0000000000005894.
To examine and quantify the potential relation between diabetic retinopathy (DR) and risk of all-cause mortality, stroke and heart failure (HF).The resources of meta-analysis of epidemiological observational studies were from Pub-med, EMBASE, CINAHL, Cochrane Library, conference, and proceedings.Random/fixed effects models were used to calculate pooled subgroup analysis stratified by different grades of DR was performed to explore the potential source of heterogeneity. Statistical manipulations were undertaken using program STATA.Of the included 25 studies, comprising 142,625 participants, 19 studies were concluded to find the relation of DR to all-cause mortality, 5 for stroke, and 3 for HF. Risk ratio (RR) for all-cause mortality with the presence of DR was 2.33 (95% CI 1.92-2.81) compared with diabetic individuals without DR. Evidences showed a higher risk of all-cause mortality associated with DR in patients with T2D or T1D (RR 2.25, 95% CI 1.91-2.65. RR 2.68, 95% CI 1.34-5.36). According to different grades of DR in patients with T2D, RR for all-cause mortality varied, the risk of nonproliferative diabetic retinopathy (NPDR) was 1.38 (1.11-1.70), while the risk of proliferative diabetic retinopathy (PDR) was 2.32 (1.75-3.06). There was no evidence of significant heterogeneity (Cochran Q test P = 0.29 vs 0.26, I = 19.6% vs 22.6%, respectively). Data from 5 studies in relation to DR and the risk of stroke showed that DR was significantly associated with increased risk of stroke (RR = 1.74, 95%CI: 1.35-2.24), compared with patients without DR. Furthermore, DR (as compared with individuals without DR) was associated with a marginal increased risk of HF in patients with diabetes mellitus (DM) (n = 3 studies; RR 2.24, 95% CI 0.98-5.14, P = 0.056).Our results showed that DR increased the risk of all-cause mortality, regardless of the different stages, compared with the diabetic individuals without DR. DR predicted increased risk of stroke and HF. Although only 3 studies about HF were available, the association between DR and HF should be careful.
为了研究和量化糖尿病视网膜病变(DR)与全因死亡率、中风和心力衰竭(HF)风险之间的潜在关系。流行病学观察性研究的荟萃分析资源来自PubMed、EMBASE、CINAHL、Cochrane图书馆、会议及会议论文集。采用随机/固定效应模型计算合并效应量,对不同DR分级进行亚组分析以探索异质性的潜在来源。使用STATA软件进行统计分析。纳入的25项研究共142,625名参与者,其中19项研究得出DR与全因死亡率的关系,5项关于中风,3项关于HF。与无DR的糖尿病个体相比,存在DR时全因死亡率的风险比(RR)为2.33(95%CI 1.92 - 2.81)。证据表明,2型糖尿病(T2D)或1型糖尿病(T1D)患者中,DR与全因死亡率风险升高相关(RR 2.25,95%CI 1.91 - 2.65;RR 2.68,95%CI 1.34 - 5.36)。根据T2D患者的不同DR分级,全因死亡率的RR有所不同,非增殖性糖尿病视网膜病变(NPDR)的风险为1.38(1.11 - 1.70),而增殖性糖尿病视网膜病变(PDR)的风险为2.32(1.75 - 3.06)。没有显著异质性的证据(Cochran Q检验P分别为0.29和0.26,I分别为19.6%和22.6%)。5项关于DR与中风风险的研究数据表明,与无DR的患者相比,DR与中风风险增加显著相关(RR = 1.74,95%CI:1.35 - 2.24)。此外,与无DR的个体相比,糖尿病(DM)患者中DR与HF风险略有增加相关(n = 3项研究;RR 2.24,95%CI 0.98 - 5.14,P = 0.056)。我们的结果表明,与无DR的糖尿病个体相比,无论处于不同阶段,DR都会增加全因死亡率风险。DR预示着中风和HF风险增加。尽管仅有3项关于HF的研究,但DR与HF之间的关联仍需谨慎对待。